Lijun Peng
ORCID: 0009-0006-6345-1425Also affiliated with Chinese Academy of Medical Sciences & Peking Union Medical College, Ruijin Hospital, Suzhou Traditional Chinese Medicine Hospital, Institut Français de la Vigne et du Vin, First Affiliated Hospital of University of South China, Shanghai Institute of Hematology, Hangzhou Red Cross Hospital, Hubei Academy of Agricultural Sciences, University of South China
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “Preclinical characterization and comparison between CD3/CD19 bispecific and novel CD3/CD19/CD20 trispecific antibodies against B-cell acute lymphoblastic leukemia: targeted immunotherapy for acute lymphoblastic leukemia”.
Lijun Peng, Wenqian Xu, Yuebo Zhou, Ziyan Zhu, Yushan Kong +5 more
Kylie E Beach, Chendi Zhu, Mingyu Gan, Wenli Wang, Hongjuan Zhou +12 more
Jin Wang, Sophie Rousseaux, Minjia Tan, Lulu Pan, Lijun Peng +19 more